| Chairman J.J. Finkelstein |
President & Chief Executive Officer RegeneRX Biopharmaceuticals, Inc. |
| Henry Bernstein | Senior Vice President Scheer Partners |
| Judy Britz | Maryland Dept of Business and Economic Development |
| Douglas Doerfler | President & Chief Executive Officer MaxCyte |
| Ed Eisenstein, Ph.D. | Acting President University of Maryland Biotech Institute |
Stanley Erck | Chief Executive Officer Novavax, Inc |
| Elizabeth Huntley | Associate Director, Public Engagement and Corporate Citizenship MedImmune |
| Rachel King | GlycoMimetics, Inc |
| Alan S. Klein | Executive Vice President Corporate Development Sequella, Inc. |
| Gerard McGarrity | Executive Vice President,
Scientific and Clinical Affairs Virxsys |
| Theodore Poehler | Research Professor Johns Hopkins University |
| Samuel (Sandy) B. Sterrett Jr. | Partner Rimon, PC |
| Russell P. Wilson | Senior Vice President, Business Development Novavax |
